Login
Navigate Fool.com
Will CPRX beat
the market?
Community Rating: 2 Stars: Unattractive

2.36 0.12 (5.36%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.24
Previous Close $2.24
Daily Range $2.24 - $2.38
52-Week Range $1.07 - $3.65
Market Cap $158.5M
P/E Ratio -7.47
Dividend (Yield) $0.00 (0.0%)
Volume 417,643
Average Daily Volume 525,812
Current FY EPS -$0.26

How do you think CPRX
will perform against the market?

Top CPRX Bull/Bear Pitches

 

zzlangerhans (< 20)
Submitted February 12, 2013

Let's see if I can catch a little bit of air with Catalyst, now that they've formally discontinued development of CPP-109 for addiction. That leaves them with CPP-109 for Tourette's and CPP-115 for in … More

0 Replies Reply Report this Post
 

zzlangerhans (< 20)
Submitted June 1, 2013

Why did a huge, successful company like Biomarin outlicense the US rights to their developmental drug Firdapse for Lambert-Eaton Syndrome to a tiny, sketchy biopharma like Catalyst? I have to admit I … More

0 Replies Reply Report this Post

News & Commentary Rss Feed

This Week in Biotech: Part 2

A look at the biggest stories this week in biotech and what they mean for investors.

Friday 6/6 Insider Buying Report: LLNW, CPRX

Sector Update: Healthcare Shares Flat Pre-Market; Catalyst Pharmaceutical Partners Rises 14% on Join

Sector Update: Healthcare Shares Flat Pre-Market; Catalyst Pharmaceutical Partners Rises 14% on Joint Study of Firdapse Tablets

Sector Update: Healthcare

US Stocks Seen Higher on Expected Yellen Support; Economic Data, Fed Minutes in Focus

US Stocks Seen Extending Gains on Fed Support

Catalyst Stock Plunge: Ugly In Orphan Drug Land

Healthcare Stocks Adding to Early Gains; Catalyst Pharma Surging Following Insider Buying

Sector Update: Healthcare

Tuesday Closing Bell: Markets Sink on Syria Worries

Stocks Drop Amid Likely Syria Intervention And Domestic Debt Ceiling Fight

See More CPRX News...

Sector

Healthcare

Industry

Drugs

CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX) Description

A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction. Website: http://www.catalystpharma.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks